Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Thermo Fisher Scientific    TMO

THERMO FISHER SCIENTIFIC

(TMO)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/19/2021 02/22/2021 02/23/2021 02/24/2021 02/25/2021 Date
478.86(c) 463.28(c) 458.81(c) 456.66(c) 451.47(c) Last
1 917 954 2 127 356 2 055 436 2 426 864 2 148 238 Volume
-2.03% -3.25% -0.96% -0.47% -1.14% Change
More quotes
Financials (USD)
Sales 2020 31 115 M - -
Net income 2020 6 136 M - -
Net Debt 2020 12 126 M - -
P/E ratio 2020 29,3x
Yield 2020 0,19%
Sales 2021 35 483 M - -
Net income 2021 7 398 M - -
Net Debt 2021 6 838 M - -
P/E ratio 2021 24,6x
Yield 2021 0,21%
Capitalization 179 B 179 B -
EV / Sales 2020 6,14x
EV / Sales 2021 5,24x
Nbr of Employees 80 000
Free-Float 90,6%
More Financials
Company
Thermo Fisher Scientific specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows: - laboratory equipments (65.4%). Moreover, the group proposes chemical products (acid, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.; -... 
More about the company
Notations Surperformance© of Thermo Fisher Scientific
Trading Rating : Investor Rating :
More Ratings
All news about THERMO FISHER SCIENTIFIC
09:17aTHERMO FISHER SCIENTIFIC : Introduces New In-line Measurement and Control System..
AQ
08:01aTHERMO FISHER SCIENTIFIC : Completes Acquisition of Mesa Biotech
PR
02/25THERMO FISHER SCIENTIFIC : Management's Discussion and Analysis of Financial Con..
AQ
02/24THERMO FISHER SCIENTIFIC : to Present at 41st Annual Cowen Healthcare Conference..
PR
02/24THERMO FISHER SCIENTIFIC INC. : Amendments to Articles of Inc. or Bylaws; Change..
AQ
02/24THERMO FISHER SCIENTIFIC : Announces Oncomine Clinical Research Grant 2021 Call ..
AQ
02/23THERMO FISHER SCIENTIFIC : Lifts Quarterly Dividend 18% to $0.26 a Share, Payabl..
MT
02/23THERMO FISHER SCIENTIFIC : Increases Quarterly Dividend
PR
02/22THERMO FISHER SCIENTIFIC : How Some Covid-19 Tests Can Flag a Key Variant
DJ
02/19THERMO FISHER SCIENTIFIC : Easy-to-Use Reversed-Phase Capillary Columns and Emit..
AQ
02/19THERMO FISHER SCIENTIFIC : Recognized with Six CMO Leadership Awards
AQ
02/18THERMO FISHER SCIENTIFIC : Year-end report 1 January – 31 December 2020
AQ
02/17INSIDER TRENDS : Thermo Fisher Scientific Insider Sale Scales Back 90-Days of Bu..
MT
02/17THERMO FISHER SCIENTIFIC : FDA Grants Emergency Use Authorization for New COVID-..
AQ
02/17THERMO FISHER SCIENTIFIC : Buys Cell Sorting Technology Assets From Propel Labs ..
MT
More news
News in other languages on THERMO FISHER SCIENTIFIC
02/09Qiagen dank Corona-Tests weiter im Aufwind
02/09DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 09.02.2021 - 15.15 Uhr
02/09KREISE : Quidel prüft Zusammenschluss mit Qiagen
02/09Aktien Frankfurt Ausblick: Dax-Anleger halten sich nach Rekord zunächst zurüc..
02/08Aktien New York Schluss: Dow endet im Plus auf Rekordhoch
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Stock Trading Strategies
THERMO FISHER SCIENTIFIC INC. - 2020
The trend should regain control
BUY
More Stock Trading Analysis
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 560,45 $
Last Close Price 451,47 $
Spread / Highest target 37,3%
Spread / Average Target 24,1%
Spread / Lowest Target -14,9%
EPS Revisions
Managers and Directors
NameTitle
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Mark P. Stevenson Chief Operating Officer & Executive Vice President
Scott M. Sperling Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
THERMO FISHER SCIENTIFIC-3.07%178 933
INTUITIVE SURGICAL, INC.-9.33%87 322
ILLUMINA, INC.20.50%65 051
KONINKLIJKE PHILIPS N.V.4.17%50 463
OLYMPUS CORPORATION1.04%27 588
CARL ZEISS MEDITEC AG15.43%13 744